Kenneth S. Cohen to Hodgkin Disease
This is a "connection" page, showing publications Kenneth S. Cohen has written about Hodgkin Disease.
Connection Strength
0.187
-
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas. Haematologica. 2022 07 01; 107(7):1608-1618.
Score: 0.187
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.